Scottish Medicines Consortium latanoprost + timolol (Fixapost)

following an abbreviated submission:

latanoprost plus timolol (Fixapost®) is accepted for restricted use within NHSScotland.

Indication under review: reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

SMC restriction: to use in patients who have proven sensitivity to preservatives.

The combination product costs less than preservative-free latanoprost and timolol eye drops administered separately but is more expensive than the equivalent generic multi-dose eye drop preparation with preservative.

To read more Press Release articles, click here.